Loading
Every trade that managers of ביולייט disclose to TASE (ISA) is tracked on this page. The last twelve months, up to 18 October 2026, brought 14 filings signed by 6 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of ביולייט has been absent for the past year.
Across the 530 companies tracked on its exchange, the median is 13 filings; at 14 filings, this issuer sits above that mark.
Every figure here comes from the filings published by TASE (ISA) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
14 of 14 declarations
Biolight is a company listed on the XTAE stock exchange, specializing in the development of innovative solutions in the healthcare sector. It focuses on the research and commercialization of advanced medical technologies.